Loading...
Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
The immunomodulatory agent, lenalidomide, is a structural analogue of thalidomide approved by the US Food and Drug Administration for the treatment of myelodysplastic syndrome (MDS) and multiple myeloma (MM). This agent is also currently under active investigation for the treatment of chronic lympho...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3409527/ https://ncbi.nlm.nih.gov/pubmed/22888354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/513702 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|